Cohance Lifesciences Ltd Q1 FY2026-2027 Results: Summary
Revenue | ₹434.51Cr |
Net Profits | ₹-24.12Cr |
Net Profit Margins | -5.55% |
Cohance Lifesciences Ltd’s revenue fell -22.89% since last year same period to ₹434.51Cr in the Q1 2026-2027. On a quarterly growth basis, Cohance Lifesciences Ltd has generated -29.61% fall in its revenue since last 3-months.
Cohance Lifesciences Ltd’s net profit fell -149.35% since last year same period to ₹-24.12Cr in the Q1 2026-2027. On a quarterly growth basis, Cohance Lifesciences Ltd has generated -223.38% fall in its net profits since last 3-months.
Cohance Lifesciences Ltd’s net profit margin fell -163.99% since last year same period to -5.55% in the Q1 2026-2027. On a quarterly growth basis, Cohance Lifesciences Ltd has generated -275.27% fall in its net profit margins since last 3-months.
FAQs
What was the revenue for Cohance Lifesciences Ltd in Q1 results 2026?
The revenue for Cohance Lifesciences Ltd in the Q1 results 2026 was ₹434.51Cr.
What was the net profit for Cohance Lifesciences Ltd in Q1 results 2026?
The net profit for Cohance Lifesciences Ltd in the Q1 results 2026 was ₹-24.12Cr.
What was the net profit margin for Cohance Lifesciences Ltd in Q1 results 2026?
The net profit margin for Cohance Lifesciences Ltd in the Q1 results 2026 was -5.55%.
What was the revenue for Cohance Lifesciences Ltd in Q1 results 2025?
The revenue for Cohance Lifesciences Ltd in the Q1 results 2025 was ₹563.48Cr.
What was the net profit for Cohance Lifesciences Ltd in Q1 results 2025?
The net profit for Cohance Lifesciences Ltd in the Q1 results 2025 was ₹48.88Cr.
What was the net profit margin for Cohance Lifesciences Ltd in Q1 results 2025?
The net profit margin for Cohance Lifesciences Ltd in the Q1 results 2025 was 8.67%.
